Ireland exported €35.2 billion of goods to the United States in the first eight months of 2026, down from €83.6 billion in the same months of 2025, a fall of 58%, according to the Central Statistics Office (CSO). The figures, published on 16 October 2026, are the latest available; the September release had not appeared when this article was written.1
What the statistics office reports
Across all destinations, Irish goods exports fell by 23.9% to €138.4 billion between January and August 2026. Exports to Great Britain rose by 38.9% to €13.2 billion over the same period, and exports to the rest of the world outside the EU, the UK and the US rose by 25%.1
The United States was still Ireland's largest market in August 2026, taking 23.7% of goods exports, or €3.8 billion. That was 8.6% less than in August 2025. Chemicals and related products, the group that includes medicines, made up 61.4% of what went to the US that month.1
The monthly pattern is uneven. In July 2026, the CSO reported exports to the US up 15.5% on a year earlier to €5.0 billion, with chemicals and related products up 13.4%.2 In the CSO's tables, exports of medical and pharmaceutical products to all destinations came to €51.6 billion from January to August 2026, against €99.6 billion a year earlier. Exports to the US of chemicals and related products, the CSO group that includes medicines, fell from €72.5 billion to €21.6 billion over the eight months, more than the whole fall in exports to the US.1
What the central bank says caused the fall
The Central Bank of Ireland, in its quarterly bulletin of 16 September 2026, wrote that customs goods exports in the first half of 2026 were 30.5% lower than a year earlier. It attributed the decline "almost entirely" to lower pharmaceutical exports to the US. Of a €54 billion fall in the goods trade surplus, it put €43 billion down to those exports.3
The bank singled out one product group: polypeptide hormones, which it associates with weight-loss drugs. Their export value was €0.5 billion in the first half of 2026, against €42 billion a year earlier. The bank said physical volumes, measured in kilograms, were comparable to 2025, so the fall reflects much lower unit values rather than a halt in production.3
The bank also linked the earlier peak to tariffs. It wrote that tariff-related stockpiling in the first quarter of 2025 was the main driver of a 20% fall in goods exports in the year to the first quarter of 2026, measured on the national accounts basis.3
The US tariffs Irish exporters now face
Ireland, as an EU member, faces the rates Washington set for the European Union. For patented medicines and their ingredients, Proclamation 11020 under Section 232 (a US law that allows tariffs on national security grounds) sets a 15% rate for EU products. The general rate is 100%. The tariff applied from 31 July 2026 to companies named in an annex and from 29 September 2026 to all others. Generic medicines are exempt.4
Austria's Federal Economic Chamber gives the same terms in its guide for exporters:
Für die Europäisch Union, Japan, Republik Korea, sowie Schweiz und Liechtenstein gemeinsam gilt ein Zollsatz in Höhe von 15%.
For the European Union, Japan, the Republic of Korea, and Switzerland and Liechtenstein jointly, a tariff rate of 15% applies.5
Most other EU goods pay the tariff that the US Trade Representative imposed from 24 July 2026 under Section 301 of the Trade Act of 1974, after finding that the EU fails to enforce its ban on goods made with forced labour. For EU goods the ordinary duty and the new tariff together come to 10%, and nothing is added where the ordinary duty is already 10% or more. Goods subject to Section 232 tariffs are exempt from it.6
How Dublin presents the trade balance
The Department of Finance has long argued that Ireland's goods surplus with the United States gives an incomplete picture. Its statement, first published in 2019 and last updated on 11 April 2025, says the goods surplus, mostly medicines, is offset by large imports of US services, including royalties and licence fees paid by the Irish chemical and pharmaceutical sector. Using 2017 figures, it put Ireland's overall trade with the United States, goods and services together, at a small deficit.7
The CSO's figures for September 2026 will be the first to include days after the pharmaceutical tariff was extended to all companies on 29 September; they had not been published by 18 November 2026.1 4